3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Glioblastoma
40
Breast Neoplasms
23
Gliosarcoma
22
Esophageal Neoplasms
21
Prostatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
19
Pancreatic Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Rectal Neoplasms
13
Glioma
13
Brain Neoplasms
13
Uterine Cervical Neoplasms
12
Neoplasms
12
Lung Neoplasms
11
Head and Neck Neoplasms
11
Melanoma
10
Astrocytoma
10
Sarcoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Central Nervous System Neoplasms
8
Stomach Neoplasms
7
Lymphoma, Follicular
6
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Adenocarcinoma Of Esophagus
6
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Carcinoma
5
Burkitt Lymphoma
5
Interventions
Radiotherapy
3
Chemotherapy, Adjuvant
3
Magnetic Resonance Spectroscopy
2
Letrozole
2
Carboplatin
2
gallium 68 PSMA-11
1
fluciclovine F-18
1
atamestane
1
Zolpidem
1
Venlafaxine Hydrochloride
1
Trastuzumab
1
Toremifene
1
Thiotepa
1
Tamoxifen
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Conformal
1
Radiosurgery
1
Radiation
1
Proton Therapy
1
Paclitaxel
1
Melphalan
1
Mass Spectrometry
1
Indocyanine Green
1
Immunohistochemistry
1
Histocompatibility Testing
1
Gene Expression Profiling
1
Fulvestrant
1
Fluorescent Antibody Technique
1
Estrogen Receptor Modulators
1
Drugs, Generic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Lobular
×
Radiation
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts